Wugen
Wugen is developing off-the-shelf cellular therapies for cancer. Our NK cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute myeloid leukemia (AML) and T-cell malignancies.
Domain
wugen.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$115.0M
Founded
2017
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Wugen use?+
We have not yet detected technologies for Wugen.
What industry is Wugen in?+
Wugen operates in the Biotechnology industry.
Where is Wugen based?+
Wugen is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026